CSF-GFAP, mainly expressed in fibrillary astrocytes, was already described to be slightly upregulated in DLB, a distinct type of other synucleinopathies, compared with controls (Ishiki et al., 2016). The gene discussed is GFAP; the disease is Lewy body dementia.